BAJAJ BROKING

Notification close image
No new Notification messages
card image
Euro Pratik Sales Ltd IPO
Apply for the Euro Pratik Sales Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

543594

DPL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

DIPNA PHARMACHEM LIMITED Share Price Update

As of the latest trading session, DIPNA PHARMACHEM LIMITED share price is currently at ₹ 21.9, which is down by ₹ -0.14 from its previous closing. Today, the stock has fluctuated between ₹ 21.00 and ₹ 22.00. Over the past year, DIPNA PHARMACHEM LIMITED has achieved a return of 169.43 %. In the last month alone, the return has been 9.76 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

DIPNA PHARMACHEM LIMITED fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    51.10

  • P/E Ratio (TTM)

    53.76

  • Beta

    0.60

  • Book Value / share

    16.00

  • Return on equity

    2.55%

  • EPS (TTM)

    0.41

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

DIPNA PHARMACHEM LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 124.92
Operating Expense 123.50
Net Profit 0.97
Net Profit Margin (%) 0.77
Earnings Per Share (EPS) 0.41
EBITDA 3.44
Effective Tax Rate (%) 31.69
Particulars MAR 2024 (Values in Cr)
Revenue 164.34
Operating Expense 162.93
Net Profit 1.09
Net Profit Margin (%) 0.66
Earnings Per Share (EPS) 0.90
EBITDA 3.44
Effective Tax Rate (%) 23.23
Particulars MAR 2023 (Values in Cr)
Revenue 99.93
Operating Expense 98.55
Net Profit 0.91
Net Profit Margin (%) 0.91
Earnings Per Share (EPS) 0.76
EBITDA 2.34
Effective Tax Rate (%) 34.05
Particulars MAR 2022 (Values in Cr)
Revenue 72.76
Operating Expense 71.19
Net Profit 1.17
Net Profit Margin (%) 1.60
Earnings Per Share (EPS) 333.39
EBITDA 2.21
Effective Tax Rate (%) 26.11
Particulars MAR 2021 (Values in Cr)
Revenue 31.00
Operating Expense 30.96
Net Profit 0.02
Net Profit Margin (%) 0.06
Earnings Per Share (EPS) 6.91
EBITDA 0.42
Effective Tax Rate (%) 50.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 16.01
ROE % 2.55
ROCE % 6.64
Total Debt to Total Equity 0.48
EBITDA Margin 3.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 15.60
ROE % 3.52
ROCE % 7.05
Total Debt to Total Equity 0.57
EBITDA Margin 2.10
Particulars MAR 2023 (Values in Cr)
Book Value / Share 20.35
ROE % 6.97
ROCE % 9.00
Total Debt to Total Equity 1.00
EBITDA Margin 2.36
Particulars MAR 2022 (Values in Cr)
Book Value / Share 496.73
ROE % 100.86
ROCE % 17.56
Total Debt to Total Equity 9.75
EBITDA Margin 3.01
Particulars MAR 2021 (Values in Cr)
Book Value / Share 163.34
ROE % 3.54
ROCE % 3.46
Total Debt to Total Equity 19.47
EBITDA Margin 1.32
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.42
Total Assets 132.37
Total Liabilities 132.37
Total Equity 38.49
Share Outstanding 24045250
Price to Book Ratio 0.89
Return on Assets (%) 0.73
Return on Capital (%) 1.75
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.87
Total Assets 132.90
Total Liabilities 132.90
Total Equity 37.51
Share Outstanding 24045250
Price to Book Ratio 0.60
Return on Assets (%) 0.81
Return on Capital (%) 1.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 5.69
Total Assets 77.55
Total Liabilities 77.55
Total Equity 24.35
Share Outstanding 11970000
Price to Book Ratio 0.62
Return on Assets (%) 1.17
Return on Capital (%) 2.26
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 36.22
Total Liabilities 36.22
Total Equity 1.73
Share Outstanding 35000
Price to Book Ratio 0.00
Return on Assets (%) 3.22
Return on Capital (%) 9.78
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 24.79
Total Liabilities 24.79
Total Equity 0.57
Share Outstanding 35000
Price to Book Ratio 0.00
Return on Assets (%) 0.09
Return on Capital (%) 0.19
Particulars MAR 2025 (Values in Cr)
Net Income 1.42
Cash from Operations -8.74
Cash from Investing -0.02
Cash from Financing -4.23
Net change in Cash -13.45
Free Cash Flow -8.72
Particulars MAR 2024 (Values in Cr)
Net Income 1.41
Cash from Operations -5.08
Cash from Investing -0.01
Cash from Financing 13.61
Net change in Cash 8.18
Free Cash Flow -5.06
Particulars MAR 2023 (Values in Cr)
Net Income 1.38
Cash from Operations -20.50
Cash from Investing -0.01
Cash from Financing 26.47
Net change in Cash 5.48
Free Cash Flow -20.49
Particulars MAR 2022 (Values in Cr)
Net Income 1.57
Cash from Operations 3.21
Cash from Investing 0.00
Cash from Financing -2.84
Net change in Cash -0.04
Free Cash Flow 3.21
Particulars MAR 2021 (Values in Cr)
Net Income 0.05
Cash from Operations -2.41
Cash from Investing 0.00
Cash from Financing 2.50
Net change in Cash 0.07
Free Cash Flow -2.40
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.05 13.08 1.75 245.61 30.00 / 68.00
BLISS GVS PHARMA LTD 151.65 15.01 1.52 1600.99 105.05 / 190.65
CIPLA LTD 1547.90 23.19 4.00 125032.25 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 356.60 10.04 2.89 1049.51 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2755.05 49.29 23.91 46672.21 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.05 17.42 5.06 245.61 30.00 / 68.00
AMRUTAJAN HEALTH LTD 761.70 40.39 6.74 2202.12 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 8998.45 106.38 29.20 22496.13 6222.35 / 10653.05
BLISS GVS PHARMA LTD 151.65 22.67 1.51 1600.99 105.05 / 190.65

DIPNA PHARMACHEM LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
21.24 -3.62 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 21.90
  • 26 Days 21.20
  • 10 Days 21.50
  • 50 Days 21.40
  • 12 Days 21.30
  • 100 Days 20.70
  • 20 Days 21.10
  • 200 Days 18.30
21.92 PIVOT

First Support

21.12

First Resistance

22.85

Second Support

20.19

Second Resistance

23.65

Third Support

19.39

Third Resistance

24.58

RSI

55.17

ADX

26.14

MACD

0.17

Williams % R

-22.33

Commodity Channel Index (CCI)

101.34

Date

2025-09-15

Week

27500.00

Same Day

15000.00

Month

34800.00

1 Year

0.61

3 Year

0.59

Over 1 Month

9.76%

down

Over 1 Year

169.43%

down

Over 3 Months

2.03%

down

Over 3 Years

-2.11%

down

Over 6 Months

72.45%

down

Over 5 Years

0.00%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

DIPNA PHARMACHEM LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
90.02%
Promoter Holdings
9.97%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Keyur Dipakkumar Shah 2397000.0 (9.97%) Shareholding of Promoter and Promoter Group
Teena Kirti Jain 987000.0 (4.1%) Public Shareholding
Dilip Keshrimal Sanklecha 921000.0 (3.83%) Public Shareholding
Kalpalabdhi Securities Private 894000.0 (3.72%) Public Shareholding
Hemant Naresh Jain Huf 789000.0 (3.28%) Public Shareholding
Sunita Santosh Goenka 533250.0 (2.22%) Public Shareholding
Namita Hemant Jain 477000.0 (1.98%) Public Shareholding
Ravi Ashok Kothari 450000.0 (1.87%) Public Shareholding
Alka Jaysing Tambe 414000.0 (1.72%) Public Shareholding
Janhavi Santosh Ghadge 390000.0 (1.62%) Public Shareholding
Neerita Sanjay Jain 342000.0 (1.42%) Public Shareholding
Sanjay Nirmal Jain Huf 306000.0 (1.27%) Public Shareholding
Ravi Bhushan Puri 300000.0 (1.25%) Public Shareholding
Nareshkumar Kapoorchand Jain 291000.0 (1.21%) Public Shareholding
Viha Ashok Jain 276000.0 (1.15%) Public Shareholding
Sahib Puniani 273000.0 (1.14%) Public Shareholding
Sonali Dilip Sanklecha 246000.0 (1.02%) Public Shareholding
Dipna Keyur Shah 2500.0 (0.01%) Shareholding of Promoter and Promoter Group
Dhara Nrupeshbhai Shah 100.0 (0.0%) Shareholding of Promoter and Promoter Group
Chaitanya Chinubhai Nanavati 100.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

DIPNA PHARMACHEM LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

DIPNA PHARMACHEM LIMITED Share Price

Dipan Pharmachem Private Limited was incorporated on July 19, 2011. Subsequently, the Company name was changed to 'Dipna Pharmachem Private Limited' on March 29, 2012. Later on, it was converted from Private Limited to Public Limited and the name of Company was changed to 'Dipna Pharmachem Limited' vide fresh Certificate of Incorporation issued by Registrar of Companies, Ahmedabad dated May 25, 2022.

Mr. Keyur Shah, being the Promoter, the Company is engaged in trading and distribution of pharmaceutical raw material and chemical formulation products, also known as APIs (Active Pharmaceutical Ingredients). Presently, its product portfolio comprises of 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovasculars, Anti - Bactaria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone, other etc. Being a trading and distribution company, it has a pan India market for products.

In FY 2022, the Company started trading of chemicals in Ahmedabad.

In August 2022, Company made a fresh issue by raising funds through IPO aggregating to Rs 15.2 Cr and by issuing 40,02,000 equity shares of Rs 10/- each.

Parent organization Indian Private
NSE symbol [-]
Founded 2011
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Dipna Pharmachem Ltd?

Answer Field

Dipna Pharmachem Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 21.24 as on Sep 16 2025 03:29 PM.

What is the Market Cap of Dipna Pharmachem Ltd Share?

Answer Field

The market cap of Dipna Pharmachem Ltd for NSE ₹ 0.00 & for BSE ₹ 51.10 as on Sep 16 2025 03:29 PM.

What is the 52 Week High and Low of Dipna Pharmachem Ltd?

Answer Field

The 52 Week High and Low of Dipna Pharmachem Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 26.31 and ₹ 6.40.

What is 1 year return for Dipna Pharmachem Ltd?

Answer Field

The 1 year returns on the stock has been 169.43%.

What is the P/E Ratio of Dipna Pharmachem Ltd Share?

Answer Field

As on Sep 16 2025 03:29 PM the price-to-earnings (PE) ratio for Dipna Pharmachem Ltd share is 53.76.

What is the PB ratio of Dipna Pharmachem Ltd Share?

Answer Field

As on Sep 16 2025 03:29 PM, the price-to-book (PB) ratio for Dipna Pharmachem Ltd share is 16.00.

How to Buy Dipna Pharmachem Ltd Share?

Answer Field

You can trade in Dipna Pharmachem Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Dipna Pharmachem Ltd Share on Bajaj Broking App?

Answer Field

To buy Dipna Pharmachem Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Dipna Pharmachem Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91